AnaptysBio : Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular Psoriasis (Form 8-K)

ANAB

Disclaimer

AnaptysBio Inc. published this content on 04 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2021 13:12:29 UTC.